MONROVIA, Calif. — Cell Care Therapeutics, Inc., a biotechnology company whose mission is to advance stem-cell derived therapies in ophthalmology, today announced the closing of a $4.3 million seed round investment from a syndicate of individual investors. This round of funding will be used to develop Cell Care’s manufacturing platform and to advance its lead preclinical-stage drug candidate for major eye diseases, including diabetic retinopathy (DR) and neovascular age-related macular degeneration (wet AMD), two of the leading causes of vision loss and blindness in the developed world. [Read more…]
Parkinson’s Disease Treatment Using Reprogrammed Stem Cells
Anyone who has ever watched a friend or loved one succumb to the slow degradation of Parkinson’s disease will understand the urge to cure it. Read on to learn more about how stem cells could be a possible treatment option for Parkinson’s disease.
In this article:
BioStem Life Sciences, Inc., Subsidiary of BioStem Technologies, Inc., Announces Entry into Market with Four Amniotic Products
Pompano Beach, FL, Oct. 01, 2018 — BioStem Life Sciences (“Life Sciences” or the “Company”), a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM), a Company focused on the development of the highest quality placental-based amniotic tissue products, whose mission is to create a new paradigm of healthcare, using breakthrough therapies that treat patients who otherwise are without effective treatment options, announced today that it has entered the market with four placental-derived tissue products for multiple indications within the ophthalmology, orthopedic and advanced wound care markets. [Read more…]
Ncardia and Nanion Technologies Align Forces to Accelerate Drug Discovery & Development
Major news broke in the iPSC sector last week when Ncardia (Cologne, Germany) and Nanion Technologies (Munich, Germany) signed a joint marketing and sales promotion agreement. Under the terms of partnership, customers of the companies will get access to high-performance instrument platforms from Nanion, coupled with Ncardia’s portfolio of hiPSC-derived cardiac cell types and assay services. [Read more…]
Your Ultimate Guide to Cell and Gene Therapy Conferences
Cell and gene therapy conferences have been rapidly multiplying over the past decade. This article is your ultimate guide to cell and gene therapy conferences worldwide. These conferences include presentations on stem cells, CAR-T, exosomes, and other types of cell and gene therapy applications.
Our goal is for this to be a comprehensive guide to cell and gene therapy events worldwide, so we welcome new additions in the comments below. [Read more…]
- « Previous Page
- 1
- …
- 109
- 110
- 111
- 112
- 113
- …
- 202
- Next Page »